Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Crest Whitestrips ad

This article was originally published in The Tan Sheet

Executive Summary

New commercial airing on major networks features comparison between P&G's Crest Whitestrips and "paint on teeth whitener," presumably a reference to Colgate-Palmolive's Simply White tooth-bleaching kit. Ad features a woman who must avoid moving her lips to keep the whitening product on her teeth. She mumbles her lines to the camera over subtitles, which read "I can't talk. I'm using that paint-on teeth whitener. If I move my lips, my saliva will wash most of it away in two minutes." A female voiceover states: "With Crest Whitestrips, the strip stays for 30 minutes, so it whitens five times better." "Now we're talking," the consumer says. Simply White debuted in September as a lower-priced alternative to Whitestrips; P&G subsequently lowered the Crest offering's price to approximately $24-$29...

You may also be interested in...



Crest Whitestrips Ad Comparison To Simply White Gets Mixed NAD Review

Procter & Gamble's recent TV ad humorously comparing Crest Whitestrips to Colgate Simply White makes an adequately supported superior whitening claim, but "falsely denigrates" the Colgate-Palmolive product, the National Advertising Division of the Council of Better Business Bureaus concludes in a recent review

Colgate Simply White Night’s Debut To Coincide With Crest Night Effects

Colgate-Palmolive is adding a nighttime application alternative to its Simply White paint-on tooth whitening brand, VP-Investor Relations Bina Thompson announced during a Feb. 4 analysts call

Parkinson’s Results Further Sweeten AbbVie’s Acquisition of Cerevel

Cerevel, which AbbVie is spending $8.7bn to acquire, unveiled topline results from the TEMPO-3 study of tavapadon, which an analyst said represents potentially a $1bn opportunity.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094815

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel